147 related articles for article (PubMed ID: 23463283)
81. Involvement of CUL4A in regulation of multidrug resistance to P-gp substrate drugs in breast cancer cells.
Wang Y; Ma G; Wang Q; Wen M; Xu Y; He X; Zhang P; Wang Y; Yang T; Zhan P; Wei G
Molecules; 2013 Dec; 19(1):159-76. PubMed ID: 24368600
[TBL] [Abstract][Full Text] [Related]
82. CacyBP/SIP expression is involved in the clinical progression of breast cancer.
Wang N; Ma Q; Wang Y; Ma G; Zhai H
World J Surg; 2010 Nov; 34(11):2545-52. PubMed ID: 20585948
[TBL] [Abstract][Full Text] [Related]
83. miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway.
Wu Y; Xu W; Yang Y; Zhang Z
Ann Clin Lab Sci; 2021 May; 51(3):310-320. PubMed ID: 34162560
[TBL] [Abstract][Full Text] [Related]
84. Low‑intensity low‑frequency ultrasound enhances the chemosensitivity of gemcitabine‑resistant ASPC‑1 cells via PI3K/AKT/NF‑κB pathway‑mediated ABC transporters.
Qiu F; Chen J; Cao J; Diao F; Huang P
Oncol Rep; 2020 Sep; 44(3):1158-1168. PubMed ID: 32705228
[TBL] [Abstract][Full Text] [Related]
85. CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.
Hong SP; Wen J; Bang S; Park S; Song SY
Int J Cancer; 2009 Nov; 125(10):2323-31. PubMed ID: 19598259
[TBL] [Abstract][Full Text] [Related]
86. Dimerization and phosphatase activity of calcyclin-binding protein/Siah-1 interacting protein: the influence of oxidative stress.
Topolska-Woś AM; Shell SM; Kilańczyk E; Szczepanowski RH; Chazin WJ; Filipek A
FASEB J; 2015 May; 29(5):1711-24. PubMed ID: 25609429
[TBL] [Abstract][Full Text] [Related]
87. CacyBP/SIP inhibits the migration and invasion behaviors of glioblastoma cells through activating Siah1 mediated ubiquitination and degradation of cytoplasmic p27.
Yan S; Li A; Liu Y
Cell Biol Int; 2018 Feb; 42(2):216-226. PubMed ID: 29024247
[TBL] [Abstract][Full Text] [Related]
88. CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family.
Filipek A; Jastrzebska B; Nowotny M; Kuznicki J
J Biol Chem; 2002 Aug; 277(32):28848-52. PubMed ID: 12042313
[TBL] [Abstract][Full Text] [Related]
89. Midkine confers Adriamycin resistance in human gastric cancer cells.
Xu YY; Mao XY; Song YX; Zhao F; Wang ZN; Zhang WX; Xu HM; Jin F
Tumour Biol; 2012 Oct; 33(5):1543-8. PubMed ID: 22576950
[TBL] [Abstract][Full Text] [Related]
90. Calcyclin-binding protein/Siah-1-interacting protein as a regulator of transcriptional responses in brain cells.
Kilanczyk E; Filipek A; Hetman M
J Neurosci Res; 2015 Jan; 93(1):75-81. PubMed ID: 25163685
[TBL] [Abstract][Full Text] [Related]
91. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
[TBL] [Abstract][Full Text] [Related]
92. Regulation of CacyBP/SIP expression by NFAT1 transcription factor.
Kądziołka B; Leśniak W; Filipek A
Immunobiology; 2017 Aug; 222(8-9):872-877. PubMed ID: 28526484
[TBL] [Abstract][Full Text] [Related]
93. [Effects of Ras antisense oligoribonucleotide on multidrug resistance of pancreatic carcinoma Pc-2 cells].
Chen X; Qin ZY; Hu ZP; Wu T; Ji ZZ; Zhang X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):633-6. PubMed ID: 16274048
[TBL] [Abstract][Full Text] [Related]
94. CacyBP/SIP promotes the proliferation of colon cancer cells.
Zhai H; Shi Y; Chen X; Wang J; Lu Y; Zhang F; Liu Z; Lei T; Fan D
PLoS One; 2017; 12(2):e0169959. PubMed ID: 28196083
[TBL] [Abstract][Full Text] [Related]
95. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K
Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089
[TBL] [Abstract][Full Text] [Related]
96. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
[TBL] [Abstract][Full Text] [Related]
97. Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin.
Jovelet C; Bénard J; Forestier F; Farinotti R; Bidart JM; Gil S
Eur J Pharm Sci; 2012 Aug; 46(5):484-91. PubMed ID: 22484209
[TBL] [Abstract][Full Text] [Related]
98. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer.
Gu J; Huang W; Wang X; Zhang J; Tao T; Zheng Y; Liu S; Yang J; Chen ZS; Cai CY; Li J; Wang H; Fan Y
Mol Cancer; 2022 May; 21(1):112. PubMed ID: 35538494
[TBL] [Abstract][Full Text] [Related]
99. Selective GPR55 antagonism reduces chemoresistance in cancer cells.
Singh NS; Bernier M; Wainer IW
Pharmacol Res; 2016 Sep; 111():757-766. PubMed ID: 27423937
[TBL] [Abstract][Full Text] [Related]
100. Relationship between CacyBP/SIP expression and prognosis in astrocytoma.
Zhao W; Wang C; Wang J; Ge A; Li Y; Li W; Lu Y
J Clin Neurosci; 2011 Sep; 18(9):1240-4. PubMed ID: 21764585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
